Skip to main content
. 2022 Oct 13;10(10):2550. doi: 10.3390/biomedicines10102550

Table 3.

Vaccination status of subjects in COVID-19 and control group.

COVID-19 (N = 49) Control (N = 50)
Total vaccination (N) 23 (47%) 36 (72%)
BioNTech 15 (65%) 20 (55%)
Johnson & Johnson 5 (22%) 9 (25%)
Moderna 3 (13%) 7 (20%)